Evidence map›Paper›PMID 35200590›Full record

ArticleCurrent oncology (Toronto, Ont.)2022

CT and 3 Tesla MRI in the TN Staging of Colon Cancer: A Prospective, Blind Study.

Søren R Rafaelsen, Claus Dam, Chris Vagn-Hansen, Jakob Møller, Hans B Rahr, Mikkel Sjöström, Jan Lindebjerg, Torben Frøstrup Hansen, Malene Roland Vils Pedersen

Abstract read
In one paragraph

Article in Current oncology (Toronto, Ont.), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Review
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Søren R RafaelsenDepartment of Radiology, Vejle Hospital, University Hospital of Southern Denmark, 7100 Vejle, Denmark.ORCID 0000-0001-5182-5545
Claus DamDepartment of Radiology, Vejle Hospital, University Hospital of Southern Denmark, 7100 Vejle, Denmark.
Chris Vagn-HansenDepartment of Radiology, Vejle Hospital, University Hospital of Southern Denmark, 7100 Vejle, Denmark.
Jakob MøllerDepartment of Radiology, Vejle Hospital, University Hospital of Southern Denmark, 7100 Vejle, Denmark.
Hans B RahrDanish Colorectal Cancer Center South, Vejle Hospital, University Hospital of Southern Denmark, 7100 Vejle, Denmark.ORCID 0000-0002-4571-7852
Mikkel SjöströmDepartment of Surgery, Vejle Hospital, University Hospital of Southern Denmark, 7100 Vejle, Denmark.
Jan LindebjergDanish Colorectal Cancer Center South, Vejle Hospital, University Hospital of Southern Denmark, 7100 Vejle, Denmark.ORCID 0000-0002-2055-4241
Torben Frøstrup HansenDanish Colorectal Cancer Center South, Vejle Hospital, University Hospital of Southern Denmark, 7100 Vejle, Denmark.ORCID 0000-0001-7476-671X
Malene Roland Vils PedersenDepartment of Radiology, Vejle Hospital, University Hospital of Southern Denmark, 7100 Vejle, Denmark.ORCID 0000-0001-5167-7968

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

(1) Background: Computer tomography (CT) scanning is currently the standard method for staging of colon cancer; however, the CT based preoperative local staging is far from optimal. The purpose of this study was to investigate the sensitivity and specificity of magnetic resonance imaging (MRI) compared to CT in the T- and N-staging of colon cancer. (2) Methods: Patients underwent a standard contrast-enhanced CT examination. For the abdominal MRI scan, a 3 Tesla unit was used, including diffusion weighted imaging (DWI). Experienced radiologists reported the CT and MRI scans blinded to each other and the endpoint of the pathological report. (3) Results: From 2018 to 2021, 134 patients received CT and MRI scans. CT identified 118 of the 134 tumors, whereas MRI identified all tumors. For discriminating between stage T3ab and T3cd, the sensitivity of CT was 51.1% and of MRI 80.0% (

Indexed as

Colonic NeoplasmsMagnetic Resonance ImagingComputersHumansNeoplasm StagingProspective StudiesTomography, X-Ray Computedcolon cancerCTDWIlymph nodeMRIt-staging

Identifiers

PMID35200590
PMCPMC8870524

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.